180 related articles for article (PubMed ID: 34975298)
1. G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression.
Zhang Q; Ni Y; Wang S; Agbana YL; Han Q; Liu W; Bai H; Yi Z; Yi X; Zhu Y; Sai B; Yang L; Shi Q; Kuang Y; Yang Z; Zhu Y
Int J Med Sci; 2022; 19(1):47-64. PubMed ID: 34975298
[No Abstract] [Full Text] [Related]
2. Silent information regulator 2 promotes clear cell renal cell carcinoma progression through deacetylation and small ubiquitin-related modifier 1 modification of glucose 6-phosphate dehydrogenase.
Ni Y; Yang Z; Agbana YL; Bai H; Wang L; Yang L; Yi Z; Cheng J; Zhang Q; Kuang Y; Zhu Y
Cancer Sci; 2021 Oct; 112(10):4075-4086. PubMed ID: 34310804
[TBL] [Abstract][Full Text] [Related]
3. G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS‑MAPK axis pathway.
Zhang Q; Han Q; Yang Z; Ni Y; Agbana YL; Bai H; Yi Z; Yi X; Kuang Y; Zhu Y
Int J Oncol; 2020 Jul; 57(1):197-212. PubMed ID: 32319593
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
5. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
[TBL] [Abstract][Full Text] [Related]
6. miR-429-CRKL axis regulates clear cell renal cell carcinoma malignant progression through SOS1/MEK/ERK/MMP2/MMP9 pathway.
Wang J; Wang C; Li Q; Guo C; Sun W; Zhao D; Jiang S; Hao L; Tian Y; Liu S; Sun MZ
Biomed Pharmacother; 2020 Jul; 127():110215. PubMed ID: 32413671
[TBL] [Abstract][Full Text] [Related]
7. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
8. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B
Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
10. NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway.
He W; Cheng F; Zheng B; Wang J; Zhao G; Yao Z; Zhang T
Aging (Albany NY); 2021 May; 13(10):14015-14038. PubMed ID: 34030133
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation.
Qi Y; Ma Y; Peng Z; Wang L; Li L; Tang Y; He J; Zheng J
Oncogene; 2020 May; 39(22):4404-4420. PubMed ID: 32341409
[TBL] [Abstract][Full Text] [Related]
12. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop.
Liu Y; Wang JX; Nie ZY; Wen Y; Jia XJ; Zhang LN; Duan HJ; Shi YH
J Exp Clin Cancer Res; 2019 Oct; 38(1):439. PubMed ID: 31747963
[TBL] [Abstract][Full Text] [Related]
14. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
[TBL] [Abstract][Full Text] [Related]
16. MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition.
He A; He S; Huang C; Chen Z; Wu Y; Gong Y; Li X; Zhou L
Aging (Albany NY); 2020 Jan; 12(2):1465-1487. PubMed ID: 31978894
[TBL] [Abstract][Full Text] [Related]
17. CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma.
Jiang N; Niu G; Pan YH; Pan W; Zhang MF; Zhang CZ; Shen H
EBioMedicine; 2020 Mar; 53():102692. PubMed ID: 32113161
[TBL] [Abstract][Full Text] [Related]
18. Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome.
Xue YJ; Chen SN; Chen WG; Wu GQ; Liao YF; Xu JB; Tang H; Yang SH; He SY; Luo YF; Wu ZH; Huang HW
J Exp Clin Cancer Res; 2019 Aug; 38(1):378. PubMed ID: 31455359
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma.
Kwiatkowski M; Krajewski A; Durślewicz J; Buchholz K; Grzanka D; Gagat M; Zabrzyński J; Klimaszewska-Wiśniewska A
Sci Rep; 2024 Apr; 14(1):9280. PubMed ID: 38654021
[TBL] [Abstract][Full Text] [Related]
20. Circ_RPL23A acts as a miR-1233 sponge to suppress the progression of clear cell renal cell carcinoma by promoting ACAT2.
Cheng L; Cao H; Xu J; Xu M; He W; Zhang W; Dong L; Chen D
J Bioenerg Biomembr; 2021 Aug; 53(4):415-428. PubMed ID: 34036483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
